$1,000 minimum order|Contact us for questions

Minimum Order of 10 vials required — 21-day lead time for ordering and COA testing
FOX04-DRI
21-Day Lead
Longevity & MitochondrialLyophilized Powder

FOX04-DRI

10mg · 2ml

SKU: fox04-dri-10mg

Senolytic peptide targeting FOXO4-p53 interaction to clear senescent cells.


Product Specifications

Strength

10mg

Volume / Qty

2ml

Form

Lyophilized Powder

Suggested Retail Price

$396.00

Dosing Guide

Recommended Dose

5-10 mg

Route

Subcutaneous

Frequency

3x weekly for 3-4 weeks

Note: Senolytic. Short cycles only.

Clinician Access Required

Sign in to view clinician pricing & place orders

FOX04-DRI is available exclusively to verified clinicians under IRB-approved research protocol PPRN-001-2025.

Per-batch COA verifiedcGMP / ISO 9001 / 503A/503B sourcedIRB-protected research use

IRB-Approved Research Protocol

PPRN-001-2025 ·IRCM-2025-467

Approved December 3, 2025 · Principal Investigator: Dr. M. Scott Mortensen, MD, MPAS, MLT

cGMP & ISO 9001
503A/503B Sources
Per-Batch
COA Tested
MD-Led
Clinical Oversight
50-State
Licensed
FoundationBundle Pricing Available

Save up to 80% with the 5,000 Foundation Bundle

FOX04-DRI is included in this clinic-tier package. Bundle includes weight loss (tirz & reta) + longevity/repair (mots-c, ghk-cu, bpc-157, epithalon) with 1 free Tirz 15mg as a bonus.

Bundle Price:$5,000
Wholesale Value:~$5,479
Patient Retail:~$25,000+

For Clinicians

Clinical Reference

Pharmacology, safety, monitoring, and dosing reference for FOX04-DRI. Always individualize based on patient context.

Mechanism of Action

Receptor / Target

FOXO4 / p53 binding peptide; senolytic agent that selectively eliminates senescent cells

Half-Life

Short (minutes); cellular effects persist longer

Onset of Action

2–4 weeks for senolytic effect

Metabolism

Proteolysis

Cautions & Contraindications

Contraindicated In

  • Active malignancy
  • Pregnancy and lactation
  • Hypersensitivity to FOXO4-DRI

Use Caution With

  • Limited human safety data
  • Use only in pulsed protocols (e.g., 3 days, then off)
  • Monitor for immune activation and inflammatory response

Suggested Labs to Monitor

CBC with differential

Baseline / 4 weeks post-cycle

hs-CRP

Baseline / 2 weeks post-cycle

Senolytic clearance can transiently raise inflammatory markers.

CMP

Baseline / 4 weeks post-cycle

Lab interpretation guidance comes from peer-reviewed literature. Always individualize based on patient context.

Reconstitution Calculator

Calculate exactly how many units to draw on a U-100 insulin syringe for your target dose. Pre-filled with FOX04-DRI defaults — adjust as needed.

Total peptide in the vial (e.g. 10mg)

Volume of BAC water used to reconstitute

Single-injection dose in micrograms

Draw to

5.0units on a U-100 syringe

Per mL

5000 mcg

Doses per vial

~40

Always double-check reconstitution math. This tool is for reference — clinician supervision required.

Plumb DISCOVER

What FOX04-DRI targets

Patient goals, biomarkers, and wearable signals this peptide addresses. Powers the future Plumb AI protocol engine.

Patient Goals

Longevity

Biomarkers Tracked

hs-CRP

Related Products

Back to All Peptides